Clinical Trials Logo

Clinical Trial Summary

This study will compare the effects of 20 mg of atorvastatin to 80 mg of atorvastatin for the prevention of atrial fibrillation after cardiothoracic surgery. The study hypothesis is that 80 mg of atorvastatin will be more effective at preventing atrial fibrillation compared to 20 mg.


Clinical Trial Description

This is a randomized, double-blind comparison of two doses of atorvastatin for prevention of post-operative atrial fibrillation. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02029534
Study type Interventional
Source Creighton University
Contact Caroline Nubel
Phone 402-280-4032
Email carolinenubel@creighton.edu
Status Recruiting
Phase Phase 4
Start date August 2013
Completion date June 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05968456 - Complexity and Frailty in Cardiothoracic and Vascular Anesthesia (CAfCA). Prospective Multicentric Observational Study
Enrolling by invitation NCT04065919 - Evaluation of Liposomal Bupivacaine Compared to Usual Care and Its Effects on Pain for Cardiac Surgery Phase 4
Not yet recruiting NCT05079724 - Acute Kidney Injury After Cardiac Surgery
Completed NCT01847859 - Pocket-size Ultrasound by Nurses in Cardiothoracic Post-operative Patients N/A
Terminated NCT01897519 - A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery Phase 2
Recruiting NCT02863250 - Australian and New Zealand Massive Transfusion Registry
Completed NCT03725098 - Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations N/A
Terminated NCT00075179 - Natrecor in Pulmonary Hypertension Phase 4
Recruiting NCT03639519 - A Trial to Assess the Impact of Ascorbic Acid on Cardiac Surgeries Outcomes and Complications'' Phase 4